Consumer Goods & Retail Global On demand · 24-48h

Global Urinary Drainage Bags Market Strategic Research Report

Global Urinary Drainage Bags Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Urinary Drainage Bags Market
$6972025
5.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Leg Bag, Night Bag

By Application: Hospital, Home Care, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BD, Teleflex, B. Braun, Coloplast, Medline Industries, Hollister, Cardinal Health, Amsino, Flexicare Medical, Urocare Products, Apexmed, Well Lead Medical, Poly Medicure, Bicakcilar Medical Devices

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 114 pages
Market size 2025
$697
Million USD
Forecast CAGR
5.1%
2025-2032
Forecast 2032
$987.3
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Urinary Drainage Bags market size is predicted to grow from US$ 697 million in 2025 to US$ 985 million in 2032; it is expected to grow at a CAGR of 5.1% from 2026 to 2032.

Urinary drainage bags are medical pouches that collect and store urine from a urinary catheter, used for patients who can't urinate normally due to surgery, incontinence, or other conditions, featuring types like discreet leg bags for daytime and larger bedside bags for overnight, designed for hygiene and patient mobility. These systems help manage bladder emptying safely, preventing infection through proper handling and regular emptying via a tap at the bottom.

In 2025, global Urine Drainage Bag sales volume reached approximately 1.19 billion units, with an average global market price of around US$ 0.6 per unit.

Rising catheterization demand driven by aging populations and chronic disease prevalence

The primary driver of the urine drainage bag market is the sustained increase in catheter use, closely linked to global population aging and the rising prevalence of chronic conditions such as urinary incontinence, benign prostatic hyperplasia (BPH), neurological disorders, and post-surgical urinary retention. Elderly patients and long-term care residents frequently require continuous urinary drainage via indwelling systems (commonly connected to a Foley catheter), which directly drives recurring demand for drainage bags as consumable devices. As life expectancy increases in regions such as Europe, North America, China, and Japan, hospitals and nursing facilities are managing higher volumes of catheterized patients, making urine drainage bags a stable, non-cyclical demand product within the medical disposables market.

Infection control requirements and CAUTI prevention protocols

Stricter infection-control standards are a major structural driver of the urine drainage bag market, particularly efforts to reduce catheter-associated urinary tract infections (CAUTI). Healthcare providers increasingly prioritize closed drainage systems, anti-reflux valves, secure connectors, and sterile single-use bags to minimize contamination risks. Clinical guidelines generally discourage routine bag reuse or unnecessary system breaks, which favors disposable, pre-sterilized urine drainage bags with improved safety features. This focus on infection prevention not only increases unit consumption in acute care and ICU settings but also accelerates replacement cycles when contamination or leakage is suspected, reinforcing steady volume growth.

Expansion of home healthcare and long-term care services

The shift of patient care from hospitals to home healthcare and long-term care facilities is another key driver accelerating the urine drainage bag market. Home-based catheter management requires products that are easy to use, hygienic, and cost-effective, making disposable urine drainage bags the preferred option for caregivers and patients. Growth in home healthcare reimbursement, early hospital discharge policies, and chronic disease management outside acute settings all contribute to higher demand for leg bags, bedside bags, and night drainage bags. This trend is especially strong in developed markets with mature homecare infrastructure and is rapidly emerging in middle-income regions as healthcare systems seek to reduce inpatient costs while maintaining patient safety.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Urinary Drainage Bags market?

What factors are driving Urinary Drainage Bags market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Urinary Drainage Bags market opportunities vary by end market size?

How does Urinary Drainage Bags break out by Type, by Application?

This report presents a comprehensive overview of the global Urinary Drainage Bags market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Leg Bag
  • Night Bag

Segment by Product

  • Indwelling Catheter Bags
  • External/Condom Catheter Bags

Segment by Materials

  • PVC Based
  • PE / PP / EVA Based
  • Other

Segment by Application

  • Hospital
  • Home Care
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Urinary Drainage Bags market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Home Care, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Urinary Drainage Bags Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$697
2025
Forecast
$987.3
2032
CAGR
5.1%
2025–2032
Regionen
5
global
Key companies
BDTeleflexB. BraunColoplastMedline IndustriesHollisterCardinal HealthAmsino
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Leg BagNight Bag
By Application
HospitalHome CareOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Leg Bag
  • 3.1.3 Night Bag
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Home Care
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BD
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Teleflex
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 B. Braun
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Coloplast
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Medline Industries
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Hollister
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Cardinal Health
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Amsino
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Flexicare Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Urocare Products
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Apexmed
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Well Lead Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Poly Medicure
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Bicakcilar Medical Devices
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Urinary Drainage Bags market?
The global Urinary Drainage Bags market is estimated at US$ 697 million in 2025 (base year) and is projected to reach US$ 985 million by 2032.
What is the forecast CAGR for the Urinary Drainage Bags market?
The market is expected to grow at a CAGR of 5.1% from 2026 to 2032, expanding from US$ 697 million in 2025 to US$ 985 million in 2032, roughly 1.4 times its base-year value.
What is Urinary Drainage Bags?
Urinary drainage bags are medical pouches that collect and store urine from a urinary catheter, used for patients who can't urinate normally due to surgery, incontinence, or other conditions, featuring types like discreet leg bags for daytime and larger bedside bags for overnight, designed for hygiene and patient mobility. These systems help manage bladder emptying safely, preventing infection through proper handling and regular emptying via a tap at the bottom.
What are the main segments of the Urinary Drainage Bags market by type?
By type, the market is segmented into Leg Bag and Night Bag.
Which applications drive demand in the Urinary Drainage Bags market?
Key applications covered include Hospital, Home Care and Other.
Who are the key players in the Urinary Drainage Bags market?
Key players profiled include BD, Teleflex, B. Braun, Coloplast, Medline Industries, Hollister, Cardinal Health and Amsino, among 14 companies covered in total.
Which regions and countries are covered for Urinary Drainage Bags?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Urinary Drainage Bags market?
Rising catheterization demand driven by aging populations and chronic disease prevalence
Who should buy the Urinary Drainage Bags market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Home Care and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Urinary Drainage Bags market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.